NCT02045056View on ClinicalTrials.gov

Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2019

Conditions
Preclinical Alzheimer's Disease
Interventions
DRUG

Gemfibrozil

DRUG

Placebo

Trial Locations (1)

40536-0230

University of Kentucky, Lexington

All Listed Sponsors
lead

Gregory Jicha, 323-5550

OTHER

NCT02045056 - Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease | Biotech Hunter | Biotech Hunter